Search
Now showing items 1-1 of 1
Cannabis use selectively modulates circulating biomarkers in the blood of schizophrenia patients
(Wiley, 2022-11)
Cannabis use disorder is frequent in schizophrenia patients, and it is associated with an earlier age of onset and poor schizophrenia prognosis. Serotonin 2A receptors (5-HT2AR) have been involved in psychosis and, like ...